Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ECOR NASDAQ:LFWD NASDAQ:NMTC NASDAQ:NRXS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeECORelectroCore$4.83-2.8%$5.08$4.16▼$19.49$39.74M0.3447,212 shs71,122 shsLFWDLifeward$0.65-4.7%$0.66$0.50▼$4.00$10.68M0.19416,970 shs489,020 shsNMTCNeuroOne Medical Technologies$0.77-6.0%$0.86$0.40▼$1.39$40.96M0.71516,878 shs402,834 shsNRXSNeurAxis$3.79+2.4%$2.76$1.33▼$6.20$37.42M3.18535,492 shs123,066 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceECORelectroCore-1.19%-2.93%0.00%-32.20%-44.65%LFWDLifeward-2.86%-12.24%+20.80%-14.25%-72.80%NMTCNeuroOne Medical Technologies-1.30%-9.68%-11.91%-8.82%-6.93%NRXSNeurAxis+0.54%+22.11%+45.67%+34.06%+34.06%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeECORelectroCore$4.83-2.8%$5.08$4.16▼$19.49$39.74M0.3447,212 shs71,122 shsLFWDLifeward$0.65-4.7%$0.66$0.50▼$4.00$10.68M0.19416,970 shs489,020 shsNMTCNeuroOne Medical Technologies$0.77-6.0%$0.86$0.40▼$1.39$40.96M0.71516,878 shs402,834 shsNRXSNeurAxis$3.79+2.4%$2.76$1.33▼$6.20$37.42M3.18535,492 shs123,066 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceECORelectroCore-1.19%-2.93%0.00%-32.20%-44.65%LFWDLifeward-2.86%-12.24%+20.80%-14.25%-72.80%NMTCNeuroOne Medical Technologies-1.30%-9.68%-11.91%-8.82%-6.93%NRXSNeurAxis+0.54%+22.11%+45.67%+34.06%+34.06%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceECORelectroCore 2.33Hold$25.50427.95% UpsideLFWDLifeward 2.50Moderate Buy$9.001,288.25% UpsideNMTCNeuroOne Medical Technologies 2.33Hold$2.23188.89% UpsideNRXSNeurAxis 3.00Buy$7.0084.70% UpsideCurrent Analyst Ratings BreakdownLatest LFWD, NMTC, ECOR, and NRXS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/8/2025ECORelectroCoreWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)10/8/2025LFWDLifewardWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)10/8/2025NMTCNeuroOne Medical TechnologiesWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)9/27/2025ECORelectroCoreWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)9/27/2025LFWDLifewardWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)9/27/2025NMTCNeuroOne Medical TechnologiesWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)9/9/2025NMTCNeuroOne Medical TechnologiesMaxim GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$3.00(Data available from 10/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookECORelectroCore$25.18M1.53N/AN/A$1.13 per share4.27LFWDLifeward$25.66M0.40N/AN/A$2.14 per share0.30NMTCNeuroOne Medical Technologies$3.45M11.16N/AN/A$0.03 per share25.67NRXSNeurAxis$3.22M11.63N/AN/A($0.27) per share-14.04Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateECORelectroCore-$11.89M-$1.62N/AN/AN/A-47.84%-221.93%-69.17%11/12/2025 (Estimated)LFWDLifeward-$28.94M-$3.120.00N/AN/A-121.80%-137.91%-90.28%11/11/2025 (Estimated)NMTCNeuroOne Medical Technologies-$12.32M-$0.15N/A∞N/A-55.44%-163.49%-78.67%12/16/2025 (Estimated)NRXSNeurAxis-$14.63M-$0.99N/A∞N/A-492.76%N/A-641.25%11/11/2025 (Estimated)Latest LFWD, NMTC, ECOR, and NRXS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails11/12/2025Q3 2025ECORelectroCore-$0.33N/AN/AN/A$7.84 millionN/A11/11/2025Q3 2025LFWDLifeward-$0.14N/AN/AN/A$6.31 millionN/A8/14/2025Q2 2025LFWDLifeward-$0.25-$0.58-$0.33-$0.58$6.62 million$5.72 million8/14/2025Q3 2025NMTCNeuroOne Medical Technologies-$0.05-$0.03+$0.02-$0.03$1.82 million$1.70 million8/6/2025Q2 2025ECORelectroCore-$0.32-$0.35-$0.03-$0.44$7.24 million$7.38 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthECORelectroCoreN/AN/AN/AN/AN/ALFWDLifewardN/AN/AN/AN/AN/ANMTCNeuroOne Medical TechnologiesN/AN/AN/AN/AN/ANRXSNeurAxisN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioECORelectroCoreN/A1.100.95LFWDLifewardN/A2.001.26NMTCNeuroOne Medical TechnologiesN/A7.135.80NRXSNeurAxisN/A0.240.23Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipECORelectroCore26.74%LFWDLifeward26.76%NMTCNeuroOne Medical Technologies16.07%NRXSNeurAxis11.77%Insider OwnershipCompanyInsider OwnershipECORelectroCore13.80%LFWDLifeward2.70%NMTCNeuroOne Medical Technologies8.90%NRXSNeurAxis26.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableECORelectroCore508.00 million6.89 millionNot OptionableLFWDLifeward6015.70 million15.28 millionOptionableNMTCNeuroOne Medical Technologies2050.00 million45.55 millionOptionableNRXSNeurAxis199.87 million6.09 millionNot OptionableLFWD, NMTC, ECOR, and NRXS HeadlinesRecent News About These CompaniesNeurAxis to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025September 18, 2025 | finance.yahoo.comNeurAxis Enters Market Offering Agreement with Craig-HallumSeptember 2, 2025 | tipranks.comNeurAxis Stock Down Following Q2 Earnings Despite Revenue GrowthAugust 18, 2025 | zacks.comNeurAxis, Inc. Reports Robust Q2 2025 GrowthAugust 13, 2025 | msn.comNeuraxis reports Q2 EPS (22c) vs. (42c) last yearAugust 12, 2025 | msn.comNeurAxis, Inc. (NRXS) Q2 2025 Earnings Call TranscriptAugust 12, 2025 | seekingalpha.comEarnings Outlook For NeuraxisAugust 11, 2025 | benzinga.comNeuraxis ends Masimo license agreement and launches employee stock planJuly 5, 2025 | investing.comNeurAxis, Inc. (NASDAQ:NRXS) Major Shareholder Acquires $800,001.00 in StockJuly 4, 2025 | insidertrades.comNeurAxis, Inc. Ends Agreement with Masimo CorporationJuly 3, 2025 | tipranks.comNeurAxis, Inc. (NRXS) Latest Stock News & Headlines - Yahoo FinanceJuly 2, 2025 | finance.yahoo.comThe Zacks Analyst Blog Highlights Microsoft, NVIDIA, Bank of America, BK Technologies and NeurAxisJune 27, 2025 | sharewise.comSNeurAxis, Inc. Expands Insurance Coverage for IB-Stim Therapy, Enhancing Access for Patients with Abdominal PainJune 17, 2025 | quiverquant.comQNeurAxis Announces New Medical Policy Coverage with Two Health Insurers, Adding 700,000 Covered LivesJune 17, 2025 | globenewswire.comNeurAxis Achieves Critical Milestone; Secures Key Academic Society Guidelines Recommendation for Treatment of Functional Abdominal Pain (FAP) in IBSJune 10, 2025 | finance.yahoo.comNeurAxis, Inc. Announces Inclusion of PENFS Technology in Pediatric Gastroenterology Guidelines for Functional Abdominal Pain TreatmentJune 10, 2025 | quiverquant.comQNeurAxis, Inc. Approves Key Proposals at Annual MeetingJune 4, 2025 | tipranks.comNeurAxis, Inc. Completes $5 Million Registered Direct Offering to Support Growth of IB-Stim TherapyMay 22, 2025 | quiverquant.comQNeurAxis Announces Closing of $5.0 Million Registered Direct OfferingMay 22, 2025 | globenewswire.comNeurAxis, Inc. Announces $5 Million Stock OfferingMay 22, 2025 | tipranks.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All Headlines2 AI Stocks With Record Breaking Rallies: Can They Continue?By Dan Schmidt | September 29, 20253 of the Most Overbought Stocks in the Market Right NowBy Ryan Hasson | October 10, 2025Why Insurance Stocks May Struggle Despite Strong HighsBy Chris Markoch | October 2, 2025Broadcom Gets Second $420 Target as CPO Win Boosts OutlookBy Leo Miller | October 10, 2025Smart Money's Big Bet on AST SpaceMobileBy Jordan Chussler | October 16, 2025LFWD, NMTC, ECOR, and NRXS Company DescriptionselectroCore NASDAQ:ECOR$4.83 -0.14 (-2.82%) Closing price 04:00 PM EasternExtended Trading$4.80 -0.04 (-0.72%) As of 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.Lifeward NASDAQ:LFWD$0.65 -0.03 (-4.66%) Closing price 04:00 PM EasternExtended Trading$0.66 +0.01 (+1.96%) As of 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.NeuroOne Medical Technologies NASDAQ:NMTC$0.77 -0.05 (-5.98%) Closing price 04:00 PM EasternExtended Trading$0.76 -0.01 (-1.71%) As of 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.NeurAxis NASDAQ:NRXS$3.79 +0.09 (+2.43%) Closing price 04:00 PM EasternExtended Trading$3.79 0.00 (0.00%) As of 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Why Intuitive Surgical Is a No-Brainer for Long-Term Investors Why Micron Stock Could Soar 35% on AI Memory Demand WesBanco Insiders Signal Confidence With Coordinated Buys The Best AI for Picking Stocks, Ranked by Performance Will D-Wave's European Expansion Keep Fueling the Rally? Can the SharkNinja Rally Continue? Analysts Think So Navitas Soars 78% on NVIDIA Update: Is This Rally Sustainable? Louis Vuitton Earnings Show Luxury Bull Market Isn’t Done Yet Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
